Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 19,001 | 12,995 | 9,030 | 6,708 | 9,613 |
| Income taxes - deferred | -3,481 | -2,653 | -1,723 | 221 | 1,667 |
| Accounts receivable | 12,592 | 1,199 | -16,082 | 10,868 | -9,469 |
| Accounts payable and accrued liabilities | -16,677 | 10,055 | 17,277 | 981 | 4,508 |
| Other Working Capital | -3,462 | -7,580 | 2,341 | 10,628 | 9,367 |
| Other Operating Activity | -3,292 | -3,695 | 1,566 | -12,199 | -11,389 |
| Operating Cash Flow | $4,681 | $10,321 | $12,409 | $17,207 | $4,297 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,714 | -688 | -236 | -194 | -2,259 |
| Purchase Of Investment | -5,463 | -5,359 | -20,119 | -33,380 | -756 |
| Sale Of Investment | 17,609 | 2,042 | 70,774 | 90,116 | 12,464 |
| Purchase Sale Intangibles | -153 | -1,705 | -217,871 | -622 | -1,266 |
| Other Investing Activity | 190 | 0 | 2,494 | 0 | 17 |
| Investing Cash Flow | $9,469 | $-5,710 | $-164,958 | $55,920 | $8,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,098 | 2,325 | N/A | 0 | 13,583 |
| Debt Repayment | -6,563 | -744 | -6,766 | -9,542 | -7,228 |
| Common Stock Repurchased | -23,508 | -17,864 | -4,494 | -18,549 | -1,786 |
| Other Financing Activity | 87 | 76 | 70 | 64 | 56 |
| Financing Cash Flow | $-22,886 | $-16,207 | $-11,190 | $-28,027 | $4,625 |
| Exchange Rate Effect | 2,209 | 1,504 | -4,897 | -3,474 | -5,622 |
| Beginning Cash Position | 92,490 | 102,582 | 271,218 | 229,592 | 218,091 |
| End Cash Position | 85,963 | 92,490 | 102,582 | 271,218 | 229,592 |
| Net Cash Flow | $-8,736 | $-11,596 | $-163,739 | $45,100 | $17,123 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,681 | 10,321 | 12,409 | 17,207 | 4,297 |
| Capital Expenditure | -2,867 | -2,393 | -218,107 | -816 | -3,525 |
| Free Cash Flow | 1,814 | 7,928 | -205,698 | 16,391 | 772 |